The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

An apparatus device may include a bio-impedance sensor configured to take a bio-impedance measurement from a body of an individual, an optical sensor configured to take an optical measurement from the body of the individual, and a processing device configured to receive a first bio-impedance measurement from the bio-impedance sensor taken during a first period of time and a first optical measurement from the optical sensor taken during the first period of time, receive first location information of the individual during the first period of time, determine a first correlation between a physiological parameter and at least one of the first location, the first bio-impedance measurement, or the first optical measurement, and determine a first level of the physiological parameter based on the first correlation.

The present disclosure relates to optical methods and devices based on pulsate behavior of blood and optical absorption spectroscopy to measure the level of water and/or other substances or compounds, such as an alcohol or lipid, in the blood and the tissues surrounding blood vessels and arteries.

A technology for a wearable medical device for monitoring medical parameters. Medical measurement data can be received at the wearable medical device from a medical measurement sensor attached to the wearable medical device or a medical measurement sensor in communication with the wearable medical device. A calibration coefficient can be determined for calibrating the wearable medical device based on the medical measurement data. The wearable medical device can be calibrated based on the calibration coefficient.

Provided is a life support device including: a sensing information acquisition unit that acquires sensing information output from a sensor that senses a state of a person; a first estimation processor that executes first estimation processing of estimating a state of substance intake of the person based on the sensing information; a second estimation processor that executes second estimation processing of estimating a state of activity of the person, the state being correlated with the state of substance intake, based on the sensing information; a life support information generator that generates life support information on the person based on an execution result of the first estimation processing and an execution result of the second estimation processing; and a life support information output unit that outputs the life support information generated.

A system for modulating bladder function is disclosed. A system for evaluating the electrophysiological function of a bladder is disclosed. Methods for performing a controlled surgical procedure on a bladder are disclosed. A system for performing controlled surgical procedures in a minimally invasive manner is disclosed. An implantable device for monitoring and/or performing a neuromodulation procedure on a bladder is disclosed.

A life management system receives data from a client device worn by a user, the data comprising biotelemetry data and activity data collected about a user wearing the client device. The life management system generates snapshot information using information from a group consisting of: the biotelemetry data, activity data, social data associated with the user, and user profile information associated with the user. The life management system generates a recommendation using portions of the snapshot information, and updates the snapshot information with the recommendation. The life management system executes a recommendation associated with the snapshot information in accordance with the user controls associated with the user.

The present invention relates to a device, system and method for less obtrusively determining a tissue characteristic of a subject, the device comprises a first control unit (11) configured to control an electromechanical transducer (31) by a first control signal (21) to transfer mechanical waves varying in a frequency range or with varying frequency content to an exposed tissue area of the subject; a second control unit (12) configured to control an electromagnetic radiation emitter (32) by a second control signal (22) to emit electromagnetic radiation towards the exposed tissue area of the subject; a radiation signal input (13) configured to obtain a radiation signal (23) indicative of electromagnetic radiation reflected from the exposed tissue area of the subject; and a processor (14) configured to determine a tissue characteristic signal (24) indicative of a tissue characteristic of the exposed tissue area of the subject derived from a frequency response or a frequency transfer function obtained from the obtained radiation signal in said frequency range or for said varying frequency content.

A toilet system comprising a bowl and an outlet, the toilet system being adapted for discerning between types of excretion excreted by a user of the toilet system, where the toilet system comprises at least one first sensor device configured to capture at least one signal indicative of a type of excretion excreted by a user of the toilet system, and at least one second sensor device configured to capture at least one signal indicative of a quantity of excretion excreted by a user of the toilet system.

A method for determining the dry weight of a patient after dialysis therapy, wherein the patient's blood volume is monitored and blood volume values are output. The blood volume values are recorded and evaluated for a predetermined period of time after reaching an ultrafiltration volume appropriately predetermined for the patient, wherein the dry weight of the patient then is determined on the basis of the rate of change of the blood volume during the predetermined period of time.